Repros Therapeutics (RPRX) trading halted with news pending
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $27.98 --0%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: -2.1%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: -2.1%
Join SI Premium – FREE
Repros Therapeutics Inc. (Nasdaq: RPRX) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Honeywell (HON) April weekly option implied volatility into quarter results
- Mobileye (MBLY) May option implied volatility into quarter results
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
